+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurocrine Biosciences Inc - logo
Uterine Leiomyoma (Uterine Fibroids) Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Uterine Leiomyoma (Uterine Fibroids) Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 226 Pages
  • Global
From
Metrorrhagia (Abnormal Uterine Bleeding) Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Metrorrhagia (Abnormal Uterine Bleeding) Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • November 2020
  • 111 Pages
  • Global
From
Endometriosis Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Endometriosis Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 308 Pages
  • Global
From
Neurocrine Biosciences Inc (NBIX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Neurocrine Biosciences Inc (NBIX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Neurocrine Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Neurocrine Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
Comprehensive Report on Neurocrine Biosciences Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Neurocrine Biosciences Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • April 2023
  • 50 Pages
From
Loading Indicator